Header cover image

German (DAX) Pharma Industry Analysis

UpdatedFeb 20, 2024
DataAggregated Company Financials
Companies11
  • 7D2.1%
  • 3M-7.7%
  • 1Y-29.9%
  • YTDn/a

The Pharma industry is up 2.4% in the last week, with Merck KGaA up 2.3%. In the past year, the industry is down 30%. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the German Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 20 Feb 2024€98.7b€70.6b-€650,504,143.0019.3x-151.8x1.4x
Thu, 18 Jan 2024€99.2b€70.6b-€650,504,143.0020.4x-152.5x1.4x
Sat, 16 Dec 2023€95.1b€70.6b-€650,606,256.0018.6x-146.1x1.3x
Mon, 13 Nov 2023€106.9b€70.6b-€625,796,256.0016.7x-170.9x1.5x
Wed, 11 Oct 2023€114.9b€72.1b€4.7b17.9x24.6x1.6x
Fri, 08 Sep 2023€125.1b€72.1b€4.7b21.9x26.9x1.7x
Sun, 06 Aug 2023€123.9b€73.9b€6.3b17.1x19.7x1.7x
Tue, 04 Jul 2023€117.4b€74.1b€6.5b18.2x18.2x1.6x
Thu, 01 Jun 2023€125.1b€74.1b€6.4b21.8x19.6x1.7x
Sat, 29 Apr 2023€132.5b€74.2b€7.6b19.7x17.4x1.8x
Mon, 27 Mar 2023€130.6b€74.2b€7.7b17.6x17x1.8x
Wed, 22 Feb 2023€140.6b€72.8b€8.4b16.8x16.8x1.9x
Fri, 20 Jan 2023€139.6b€72.8b€8.4b15.6x16.7x1.9x
Sun, 18 Dec 2022€129.2b€72.8b€8.4b14.5x15.4x1.8x
Tue, 15 Nov 2022€132.9b€72.0b€8.2b14.6x16.2x1.8x
Thu, 13 Oct 2022€122.1b€70.5b€7.8b13x15.7x1.7x
Sat, 10 Sep 2022€130.7b€70.5b€7.8b17x16.8x1.9x
Mon, 08 Aug 2022€136.2b€70.5b€7.8b14.5x17.5x1.9x
Wed, 06 Jul 2022€130.8b€67.8b€5.6b22.9x23.3x1.9x
Fri, 03 Jun 2022€143.6b€67.8b€5.6b23.5x25.6x2.1x
Sun, 01 May 2022€142.2b€64.9b€4.3b29.7x33.4x2.2x
Tue, 29 Mar 2022€143.4b€64.8b€4.2b28.5x34.1x2.2x
Thu, 24 Feb 2022€132.6b€63.1b€3.1b30.7x43.3x2.1x
Sat, 22 Jan 2022€139.3b€63.1b€3.1b32.5x45.5x2.2x
Mon, 20 Dec 2021€146.5b€63.1b€3.1b35.6x47.8x2.3x
Wed, 17 Nov 2021€148.6b€63.0b€3.0b37.5x49.1x2.4x
Fri, 15 Oct 2021€135.7b€61.2b-€4,717,516,252.0036.8x-28.8x2.2x
Sun, 12 Sep 2021€138.8b€61.2b-€4,716,670,252.0032.4x-29.4x2.3x
Tue, 10 Aug 2021€131.8b€61.2b-€4,716,670,252.0030.7x-27.9x2.2x
Mon, 03 May 2021€120.7b€59.6b-€12,510,147,423.0027.9x-9.6x2x
Price to Earnings Ratio

-8.2x


Total Market Cap: €111.3bTotal Earnings: -€13,556,792,870.00Total Revenue: €59.8bTotal Market Cap vs Earnings and Revenue0%0%0%
German Pharma Industry Price to Earnings3Y Average -2.1x202220232024
Current Industry PE
  • Investors are pessimistic on the German Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 5.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does German Pharma compare with similar industries?

DE Market0.28%
Healthcare1.86%
Pharma2.13%
Pharma2.13%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MRK Merck KGaA€155.752.3%
+€1.5b
-15.6%PE23.4x
BAYN Bayer€28.902.0%
+€564.9m
-51.0%PS0.6x
93M1 MPH Health Care€22.5020.3%
+€16.3m
39.3%PE1.9x
HIGH Cantourage Group€8.9012.7%
+€12.5m
-14.1%n/a
SBX SynBiotic€9.0417.1%
+€6.2m
-28.7%PS5.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.